# 2026年1月6日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 糖皮质激素治疗与非HIV免疫抑制性隐球菌性脑膜炎感染后炎症综合征患者的长期结局：一项多中心病例系列研究

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486473)
**期刊：** The Journal of infectious diseases
**PMID：** 41486473
**DOI：** 10.1093/infdis/jiaf620

### 第一部分 原文与翻译

**英文原标题：** Corticosteroid Therapy and Long-Term Outcomes of Post-Infectious Inflammatory Syndrome in Non-HIV Immunosuppressed Cryptococcal Meningitis: A Multicenter Case Series.

> **英文摘要：**
> BACKGROUND: Post-infectious inflammatory response syndrome (PIIRS) is recognized as a cause of neurologic deterioration in previously healthy patients with cryptococcal meningoencephalitis (CM). However, data on non-human immunodeficiency virus (HIV), immunosuppressed patients remain limited.
> 
> METHODS: Between July 2018 and April 2025, 13 non-HIV immunosuppressed patients with CM who subsequently developed PIIRS were included. Clinical features, Karnofsky performance scores, cerebrospinal fluid (CSF) parameters, and magnetic resonance imaging (MRI) findings were compared at PIIRS diagnosis and during follow-up after corticosteroid therapy.
> 
> RESULTS: All patients showed evidence of CNS inflammation, including abnormal CSF, MRI findings, and neurological symptoms such as altered mental status or visual/hearing loss. Corticosteroid therapy was associated with significant improvements in Karnofsky scores at 1 month (P = .001), with sustained benefit at 6 and twelve months (P = .002); all 10 surviving patients demonstrated resolution of neurological symptoms. CSF inflammatory parameters including white blood cell (WBC) count, protein, and CSF/serum glucose ratio also significantly improved at 1 month. Brain MRI findings also showed a trend toward improvement. All patients remained culture-negative post-PIIRS diagnosis. Three patients died: 1 from complications of alcoholic cirrhosis, the second from liver failure in the setting of systemic lupus erythematosus and immunosuppression, and the third from sepsis after initiation of corticosteroids.
> 
> CONCLUSIONS: Corticosteroids were associated with improvement in neurological status and neuroinflammation in non-HIV, immunosuppressed patients with PIIRS following CM. These findings support its potential role as salvage therapy in this population and highlight the need for systematic data collection or randomized trials to better guide corticosteroid use.

> **中文摘要：**
> 背景：感染后炎症反应综合征（PIIRS）被认为是既往健康的隐球菌性脑膜脑炎（CM）患者出现神经功能恶化的原因之一。然而，关于非人类免疫缺陷病毒（HIV）感染的免疫抑制患者的资料仍然有限。
> 
> 方法：2018年7月至2025年4月期间，纳入13例非HIV免疫抑制状态下的CM患者，这些患者继发发生了PIIRS。研究比较了患者在PIIRS确诊时及糖皮质激素治疗随访期间的临床特征、Karnofsky功能评分、脑脊液（CSF）参数及磁共振成像（MRI）表现。
> 
> 结果：所有患者均表现出中枢神经系统炎症的证据，包括异常的CSF指标、MRI发现及神经系统症状（如意识状态改变或视力/听力丧失）。糖皮质激素治疗与1个月时Karnofsky评分显著改善相关（P = 0.001），且在6个月和12个月时疗效持续（P = 0.002）；所有10名存活患者的神经症状均消失。CSF炎症指标（包括白细胞计数、蛋白水平及CSF/血清葡萄糖比值）在1个月后亦明显改善。脑MRI结果显示出改善趋势。所有患者在PIIRS诊断后均保持培养阴性。3例患者死亡：1例死于酒精性肝硬化并发症，1例死于系统性红斑狼疮合并免疫抑制所致肝功能衰竭，另1例在糖皮质激素治疗开始后死于败血症。
> 
> 结论：糖皮质激素治疗与非HIV免疫抑制患者继发CM后PIIRS的神经功能改善及神经炎症缓解相关。这些结果支持其作为挽救性治疗的潜在作用，并强调了开展系统性数据收集或随机对照试验以更好指导糖皮质激素使用的必要性。

### 第二部分 AI 大师评价

该研究系统分析了非HIV免疫抑制状态隐球菌性脑膜炎患者中PIIRS的临床结局，探讨了糖皮质激素治疗的长期影响。结果显示，糖皮质激素可显著改善患者神经功能评分及脑脊液炎症指标，治疗效应可持续数月。其多中心病例结果为临床提供了重要救治依据，但样本量有限且非随机设计仍限制了结论的推广性。研究创新地填补了免疫抑制人群PIIRS治疗的研究空白。

---

## 2. 无需屏气的盐水对比电阻抗断层成像肺灌注评估：一项随机交叉试验

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41486260)
**期刊：** Critical care (London, England)
**PMID：** 41486260
**DOI：** 10.1186/s13054-025-05823-8

### 第一部分 原文与翻译

**英文原标题：** Lung perfusion estimation by saline-contrast EIT without breath hold: a randomized cross-over trial.

> **英文摘要：**
> INTRODUCTION: This study aimed to develop and validate a non-breath-holding contrast-enhanced electrical impedance tomography (EIT) method using low-pass filtering for bedside assessment of regional lung perfusion in mechanically ventilated ICU patients.
> 
> METHODS: This was a randomized cross-over trial. Each patient received two 10 mL 10% NaCl bolus injections via a central venous catheter, performed respectively during an end-expiratory pause (apnea) and during ongoing mechanical ventilation (non-apnea). In the non-apnea method, a 0.17 Hz low-pass filter was used to remove respiratory interference during perfusion analysis. Pixel-wise correlation was assessed using Spearman correlation analysis.
> 
> RESULTS: 20 mechanically ventilated ICU patients were included in the final analysis. Pixel-wise perfusion correlation between apnea and non-apnea methods showed good overall consistency (median r = 0.94, IQR 0.90-0.97). Global V/Q match%, dead space%, and shunt% were comparable between the two methods. The impedance drop duration was significantly shorter in the non-apnea method (5.3 s vs. 6.1 s, p = 0.008).
> 
> CONCLUSION: The non-apnea contrast-EIT method provides consistent lung perfusion images with the conventional apnea method, expanding EIT applicability to patients intolerant to apnea and potentially yielding more physiologically realistic results.

> **中文摘要：**
> 引言：本研究旨在开发并验证一种无需屏气的低通滤波盐水对比增强电阻抗断层成像（EIT）方法，用于机械通气重症监护患者床旁区域性肺灌注评估。
> 
> 方法：这是一项随机交叉试验。每位患者经中心静脉导管分别在呼气末暂停（屏气）和持续机械通气（非屏气）状态下注射两次10 mL 10%氯化钠快速推注。非屏气方法中使用0.17 Hz低通滤波以消除呼吸干扰，进行灌注分析。采用Spearman相关分析评估逐像素相关性。
> 
> 结果：最终分析纳入20例接受机械通气的ICU患者。屏气与非屏气方法的逐像素灌注相关性显示总体一致性良好（中位r=0.94，四分位距0.90–0.97）。两种方法在全局通气/灌注匹配百分比、死腔百分比及分流百分比方面相当。非屏气方法中阻抗下降持续时间显著短于屏气方法（5.3秒 vs. 6.1秒，p=0.008）。
> 
> 结论：非屏气对比EIT方法可获得与传统屏气方法一致的肺灌注图像，拓展了EIT在不能耐受屏气患者中的适用性，并可能获得更符合生理的结果。

### 第二部分 AI 大师评价

该研究提出并验证了一种创新的无需屏气的对比增强EIT肺灌注评估方法，通过低通滤波技术有效消除呼吸干扰。在随机交叉试验中，结果显示该方法与传统屏气法具有高度一致性，并保持灌注参数的可比性。此方法显著简化了操作流程，改善了临床适用性，尤其适用于重症或无法屏气患者。研究的创新在于将EIT拓展至动态呼吸条件下应用，但样本量有限及临床验证范围仍需进一步扩大。

---

速递结束，祝您工作愉快！